Chemoinformaics analysis of 2-Octenoic acid, 4,5,7-trhydroxy
| Molecular Weight | 190.195 | nRot | 5 |
| Heavy Atom Molecular Weight | 176.083 | nRig | 2 |
| Exact Molecular Weight | 190.084 | nRing | 0 |
| Solubility: LogS | -0.089 | nHRing | 0 |
| Solubility: LogP | -1.54 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 26.7051 |
| nHD | 4 | BPOL | 14.9129 |
| QED | 0.368 |
| Synth | 3.468 |
| Natural Product Likeliness | 1.215 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.014 |
| Pgp-sub | 0.991 |
| HIA | 0.227 |
| CACO-2 | -5.184 |
| MDCK | 0.00403888 |
| BBB | 0.568 |
| PPB | 0.270761 |
| VDSS | 0.641 |
| FU | 0.825918 |
| CYP1A2-inh | 0.004 |
| CYP1A2-sub | 0.096 |
| CYP2c19-inh | 0.016 |
| CYP2c19-sub | 0.116 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.404 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.117 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.099 |
| CL | 2.113 |
| T12 | 0.929 |
| hERG | 0.034 |
| Ames | 0.03 |
| ROA | 0.024 |
| SkinSen | 0.721 |
| Carcinogencity | 0.02 |
| EI | 0.816 |
| Respiratory | 0.869 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.930353 |